Federal Register / Vol. 77, No. 49 / Tuesday, March 13, 2012 / Notices 14837 

NUCLEAR REGULATORY 

COMMISSION 

[NRC–2012–0057] 

Bioassay at Uranium Mills 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: Draft regulatory guide; request 

for comment. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC or the Commission) 

is issuing for public comment draft 

regulatory guide (DG), DG–8051, 

‘‘Bioassay at Uranium Mills.’’ This 

guide describes a bioassay program 

acceptable to the NRC staff for uranium 

mills and applicable portions of 

uranium conversion facilities where the 

possibility of exposure to yellowcake 

dust exists, including exposure 

conditions with and without the use of 

respiratory protection devices. 

DATES: Submit comments by May 11, 

2012. Comments received after this date 

will be considered if it is practical to do 

so, but the NRC is able to ensure 

consideration only for comments 

received on or before this date. 

Although a time limit is given, 

comments and suggestions in 

connection with items for inclusion in 

guides currently being developed or 

improvements in all published guides 

are encouraged at any time. 

ADDRESSES: You may access information 

and comment submissions related to 

this document, which the NRC 

possesses and is publicly available, by 

searching on http://www.regulations.gov 

under Docket ID NRC–2012–0057. You 

may submit comments by the following 

methods: 

• Federal Rulemaking Web site: Go to 

http://www.regulations.gov and search 

for Docket ID NRC–2012–0057. Address 

questions about NRC dockets to Carol 

Gallagher; telephone: 301–492–3668; 

email: Carol.Gallagher@nrc.gov. 

• Mail comments to: Cindy Bladey, 

Chief, Rules, Announcements, and 

Directives Branch (RADB), Office of 

Administration, Mail Stop: TWB–05– 

B01M, U.S. Nuclear Regulatory 

Commission, Washington, DC 20555– 

0001. 

• Fax comments to: RADB at 301– 

492–3446. 

For additional direction on accessing 

information and submitting comments, 

see ‘‘Accessing Information and 

Submitting Comments’’ in the 

SUPPLEMENTARY INFORMATION section of 

this document. 

FOR FURTHER INFORMATION CONTACT: R. 

A. Jervey, Office of Nuclear Regulatory 

Research, U.S. Nuclear Regulatory 

Commission, Washington, DC 20555– 

0001; telephone: 301–251–7404; or 

email Richard.Jervey@nrc.gov. 

SUPPLEMENTARY INFORMATION: 

I. Accessing Information and 

Submitting Comments 

A. Accessing Information 

Please refer to Docket ID NRC–2012– 

0057 when contacting the NRC about 

the availability of information regarding 

this document. You may access 

information related to this document, 

which the NRC possesses and is 

publicly available, by the following 

methods: 

• Federal Rulemaking Web Site: Go to 

http://www.regulations.gov and search 

for Docket ID NRC–2012–0057. 

• NRC’s Agencywide Documents 

Access and Management System 

(ADAMS): You may access publicly 

available documents online in the NRC 

Library at http://www.nrc.gov/readingrm/adams.html. To begin the search, 

select ‘‘ADAMS Public Documents’’ and 

then select ‘‘Begin Web-based ADAMS 

Search.’’ For problems with ADAMS, 

please contact the NRC’s Public 

Document Room (PDR) reference staff at 

1–800–397–4209, 301–415–4737, or by 

email to pdr.resource@nrc.gov. The draft 

regulatory guide is available under 

ADAMS accession No. ML110960333. 

The regulatory analysis may be found in 

ADAMS under accession No. 

ML110960341. 

Regulatory guides are not 

copyrighted, and NRC approval is not 

required to reproduce them. 

II. Further Information 

The NRC is issuing for public 

comment a draft guide in the agency’s 

‘‘Regulatory Guide’’ series. This series 

was developed to describe and make 

available to the public such information 

as methods that are acceptable to the 

NRC staff for implementing specific 

parts of the NRC’s regulations, 

techniques that the staff uses in 

evaluating specific problems or 

postulated accidents, and data that the 

staff needs in its review of applications 

for permits and licenses. 

The draft regulatory guide, entitled, 

‘‘Bioassay at Uranium Mills,’’ is 

temporarily identified by its task 

number, DG–8051, which should be 

mentioned in all related 

correspondence. DG–8051 is proposed 

Revision 2 of Regulatory Guide 8.22, 

previously revised in August 1988. 

This guide is being updated to 

incorporate changes made in 10 CFR 

Part 20 since Regulatory Guide 8.22, 

Revision 1 was issued. Comments 

related to the operation of in-situ 

recovery mills and associated 

considerations for bioassay are of 

particular interest. 

Dated at Rockville, Maryland, this 6th day 

of March, 2012. 

For the Nuclear Regulatory Commission. 

Thomas H. Boyce, 

Chief, Regulatory Guide Development Branch, 

Division of Engineering, Office of Nuclear 

Regulatory Research. 

[FR Doc. 2012–6001 Filed 3–12–12; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

Advisory Committee on the Medical 

Uses of Isotopes: Meeting Notice 

AGENCY: U.S. Nuclear Regulatory 

Commission. 

ACTION: Notice of meeting. 

SUMMARY: NRC will convene a meeting 

of the Advisory Committee on the 

Medical Uses of Isotopes (ACMUI) on 

April 16–17, 2012. A sample of agenda 

items to be discussed during the public 

session includes: (1) Fundamental 

concepts in patient advocacy; (2) 

electronic signatures for documents that 

are required to be signed in accordance 

with U.S. Nuclear Regulatory 

Commission (NRC) regulations; (3) 

medical-related events from fiscal year 

2011; (4) an update on proposed 

regulatory changes for Permanent 

Implant Brachytherapy programs; (5) the 

status of the Commission Paper on data 

collection for Patient Release; (6) a 

status update on 10 CFR Part 35 

rulemaking; (7) medical use of radium223 chloride; (8) an update on strontium 

breakthrough with rubidium-82 

generators from NRC and FDA 

perspectives; and (9) half-life activity as 

a function of solar activity. The agenda 

is subject to change. The current agenda 

and any updates will be available at 

http://www.nrc.gov/reading-rm/doccollections/acmui/agenda or by 

emailing Ms. Sophie Holiday at the 

contact information below. 

Purpose: Discuss issues related to 10 

CFR Part 35 Medical Use of Byproduct 

Material. 

Date and Time for Closed Session: 

April 16, 2012, from 8 a.m. to 10:45 a.m. 

This session will be closed so that 

ACMUI members can prepare for an 

upcoming Commission briefing. 

Date and Time for Open Sessions: 

April 16, 2012, from 10:45 a.m. to 5 p.m. 

and April 17, 2012, from 8 a.m. to 12:30 

p.m. 

Address for Public Meeting: U.S. 

Nuclear Regulatory Commission, Two 

White Flint North Building, Room T2– 

mstockstill on DSK4VPTVN1PROD with NOTICES

14838 Federal Register / Vol. 77, No. 49 / Tuesday, March 13, 2012 / Notices 

B3, 11545 Rockville Pike, Rockville, 

Maryland 20852. 

Public Participation: Any member of 

the public who wishes to participate in 

the meeting in person or via phone 

should contact Ms. Holiday using the 

information below. The meeting will 

also be webcast live: http:// 

www.nrc.gov/public-involve/publicmeetings/webcast-live.html. 

Contact Information: Sophie J. 

Holiday, email: sophie.holiday@nrc.gov, 

telephone: (301) 415–7865. 

Conduct of the Meeting 

Leon S. Malmud, M.D., will chair the 

meeting. Dr. Malmud will conduct the 

meeting in a manner that will facilitate 

the orderly conduct of business. The 

following procedures apply to public 

participation in the meeting: 

1. Persons who wish to provide a 

written statement should submit an 

electronic copy to Ms. Holiday at the 

contact information listed above. All 

submittals must be received by April 9, 

2012, and must pertain to the topic on 

the agenda for the meeting. 

2. Questions and comments from 

members of the public will be permitted 

during the meeting, at the discretion of 

the Chairman. 

3. The draft transcript will be 

available on ACMUI’s Web site (http:// 

www.nrc.gov/reading-rm/doccollections/acmui/tr/) on or about May 

18, 2012. A meeting summary will be 

available on ACMUI’s Web site (http:// 

www.nrc.gov/reading-rm/doccollections/acmui/meeting-summaries/) 

on or about May 29, 2012. 

4. Persons who require special 

services, such as those for the hearing 

impaired, should notify Ms. Holiday of 

their planned attendance. 

This meeting will be held in 

accordance with the Atomic Energy Act 

of 1954, as amended (primarily Section 

161a); the Federal Advisory Committee 

Act (5 U.S.C. App); and the 

Commission’s regulations in Title 10, 

U.S. Code of Federal Regulations, Part 7. 

Dated: March 7, 2012. 

Andrew L. Bates, 

Advisory Committee Management Officer. 

[FR Doc. 2012–5998 Filed 3–12–12; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

[NRC–2012–0002] 

Sunshine Act Meeting 

AGENCY HOLDING THE MEETINGS: Nuclear 

Regulatory Commission, [NRC–2012– 

0002]. 

DATE: Weeks of March 12, 19, 26, April 

2, 9, 16, 2012. 

PLACE: Commissioners’ Conference 

Room, 11555 Rockville Pike, Rockville, 

Maryland. 

STATUS: Public and closed. 

Week of March 12, 2012 

There are no meetings scheduled for 

the week of March 12, 2012. 

Week of March 19, 2012—Tentative 

There are no meetings scheduled for 

the week of March 19, 2012. 

Week of March 26, 2012—Tentative 

Tuesday, March 27, 2012 

9 a.m.—Briefing on License Renewal for 

Research and Test Reactors (Public 

Meeting) (Contact: Jessie 

Quichocho, 301–415–0209). 

This meeting will be webcast live at 

the Web address—www.nrc.gov. 

Week of April 2, 2012—Tentative 

Tuesday April 3, 2012 

9:30 a.m.—Meeting with Organization of 

Agreement States (OAS) and 

Conference of Radiation Control 

Program Directors (CRCPD) (Public 

Meeting) (Contact: Cindy Flannery, 

301–415–0223). 

This meeting will be webcast live at 

the Web address—www.nrc.gov. 

Week of April 9, 2012—Tentative 

Tuesday, April 10, 2012 

9 a.m.—Briefing on the Final Report of 

the Blue Ribbon Commission on 

America’s Nuclear Future (Public 

Meeting) (Contact: Alicia Mullins, 

301–492–3351). 

This meeting will be webcast live at 

the Web address—www.nrc.gov. 

Week of April 16, 2012—Tentative 

There are no meetings scheduled for 

the week of April 16, 2012. 

* * * * * 

* The schedule for Commission 

meetings is subject to change on short 

notice. To verify the status of meetings, 

call (recording)—301–415–1292. 

Contact person for more information: 

Rochelle Bavol, 301–415–1651. 

* * * * * 

The NRC Commission Meeting 

Schedule can be found on the Internet 

at: http://www.nrc.gov/public-involve/ 

public-meetings/schedule.html. 

* * * * * 

The NRC provides reasonable 

accommodation to individuals with 

disabilities where appropriate. If you 

need a reasonable accommodation to 

participate in these public meetings, or 

need this meeting notice or the 

transcript or other information from the 

public meetings in another format (e.g. 

braille, large print), please notify Bill 

Dosch, Chief, Work Life and Benefits 

Branch, at 301–415–6200, TDD: 301– 

415–2100, or by email at 

william.dosch@nrc.gov. Determinations 

on requests for reasonable 

accommodation will be made on a caseby-case basis. 

* * * * * 

This notice is distributed 

electronically to subscribers. If you no 

longer wish to receive it, or would like 

to be added to the distribution, please 

contact the Office of the Secretary, 

Washington, DC 20555 (301–415–1969), 

or send an email to 

darlene.wright@nrc.gov. 

Dated: March 8, 2012. 

Rochelle C. Bavol, 

Policy Coordinator, Office of the Secretary. 

[FR Doc. 2012–6148 Filed 3–9–12; 4:15 pm] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

[Docket No. 70–7016; NRC–2009–0157] 

General Electric-Hitachi Global Laser 

Enrichment LLC, Commercial LaserBased Uranium Enrichment Facility, 

Wilmington, North Carolina; NUREG– 

2120 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: Notice of availability of safety 

evaluation report. 

SUMMARY: The Nuclear Regulatory 

Commission (NRC or the Commission) 

is considering the issuance of a license 

to General Electric-Hitachi Global Laser 

Enrichment LLC (GLE or the applicant) 

to authorize construction of a laserbased uranium enrichment facility and 

possession and use of byproduct 

material, source material, and special 

nuclear material (SNM). This proposed 

facility is proposed to be located in 

Wilmington, North Carolina. The NRC 

prepared a Safety Evaluation Report 

(SER) in support of this license 

application. 

ADDRESSES: Please refer to Docket ID 

NRC–2009–0157 when contacting the 

NRC about the availability of 

information regarding this document. 

You may access information related to 

this document, which the NRC 

possesses and is publicly-available, 

using the following methods: 

• Federal Rulemaking Web site: Go to 

http://www.regulations.gov and search 

for Docket ID NRC–2009–0157. Address 

mstockstill on DSK4VPTVN1PROD with NOTICES